-
Price Momentum
VBIO is trading near the bottom of its 52-week range and below its 200-day simple moving average.
-
Price change
The price of VBIO shares has decreased $0.11 since the market last closed. This is a 4.93% drop.
-
Last closed at $2.12.
Key terms
About VBIO
Valion Bio, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in San Antonio, TX.
-
Market cap: $1.88M
A market capitalization up to $300 million places VBIO in the micro-capitalization category.
Key terms
Smart score
Latest VBIO news
No recent press releases are available for VBIO
VBIO Financials
-
VBIO total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Net income: -$8.76M (1Y), -$7.06M (Q2)
Net Income decreased 54.92% since last year and decreased 13.37% since last quarter.
-
Earnings per share: -$189.54 (1Y), -$52.54 (Q2)
EPS increased 61.47% since last year and increased 2.29% since last quarter.
Key terms
VBIO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VBIO Competitors
-
How competitors are chosen
VBIO's competitors are included in the Health Technology sector and Medical Specialties group
-
Market cap: $1.88M
A market capitalization up to $300 million places VBIO in the micro-capitalization category.
